Cost-Effectiveness Benefits of a Disease Management Program: The REMADHE Trial Results

Edimar Alcides Bocchi*, Fatima das Dores da Cruz, Sara Michelly Brandao, Victor Issa, Silvia Moreira Ayub-Ferreira, Hans-Peter Brunner la Rocca, Sandra Sanders van Wijk

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)627-637
Number of pages11
JournalJournal of Cardiac Failure
Volume24
Issue number10
DOIs
Publication statusPublished - Oct 2018

Keywords

  • Heart failure
  • cost-effectiveness
  • disease management program
  • cost
  • CHRONIC HEART-FAILURE
  • ECONOMIC BURDEN
  • HEALTH-CARE
  • FOLLOW-UP
  • GUIDELINES
  • ADHERENCE
  • IMPACT
  • HF
  • CARDIOMYOPATHY
  • ELABORATION

Cite this